[Gabapentin in the treatment of ocular neuromyotonia].
Porta-Etessam
J
J
Unidad de Neurooftalmología y Cefaleas, Hospital Universitario Clínico San Carlos, Madrid, Spain. jporta@yahoo.com
Parejo-Carbonell
B
B
Gómez-Vicente
L
L
Marcos-De Vega
M A
MA
D000328:Adult; D000588:Amines / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D005128:Eye Diseases / Q000188:drug therapy* / Q000503:physiopathology; D000077206:Gabapentin; D006801:Humans; D020386:Isaacs Syndrome / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin